Good Place. Good Things. Good Time.

Opinion: STAT+: Rewriting the playbook for digital therapeutics

Opinion: STAT+: Rewriting the playbook for digital therapeutics

The acceleration of investment in digital health and adoption of health-related apps triggered by the pandemic, which aimed to expand access at a time when access was difficult and health care needs were growing, may be harming the particularly important subset known as digital therapeutics (DTx).

Health apps constitute a broad category, focusing on everything from health and well-being to treatment of disease. They may be unvalidated or based on limited evidence, essentially a caveat emptor situation. Digital therapeutics, in contrast, deliver medical interventions using evidence-based, clinically evaluated software, with a focus on treating, managing, and preventing diseases and disorders such as asthma and musculoskeletal pain. A growing problem with digital therapeutics, a subset of which are prescribed by clinicians, is that they often have a less-than-rigorous evidence base than should be expected.

Continue to STAT+ to read the full story…

Search more articles here: Opinion: STAT+: Rewriting the playbook for digital therapeutics

Read original article here: Opinion: STAT+: Rewriting the playbook for digital therapeutics



Disclaimers and Denial of responsibility..!

Denial of responsibility! TheTopMag.com is an automatic aggregator of all media around the world. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – jamesonline999@gmail.com . The content will be deleted within 72 hours.
You might also like
Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.